NDC 51662-1477
ENALAPRILAT
Enalaprilat
ENALAPRILAT is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Hf Acquisition Co Llc, Dba Healthfirst. The primary component is Enalaprilat.
| Product ID | 51662-1477_9d88f915-13de-5463-e053-2a95a90a09bf |
| NDC | 51662-1477 |
| Product Type | Human Prescription Drug |
| Proprietary Name | ENALAPRILAT |
| Generic Name | Enalaprilat |
| Dosage Form | Injection |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2020-02-01 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA078687 |
| Labeler Name | HF Acquisition Co LLC, DBA HealthFirst |
| Substance Name | ENALAPRILAT |
| Active Ingredient Strength | 1 mg/mL |
| Pharm Classes | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA],Decreased Blood Pressure [PE] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |